The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections J Machhi, J Herskovitz, AM Senan, D Dutta, B Nath, MD Oleynikov, ... Journal of neuroimmune pharmacology 15, 359-386, 2020 | 757 | 2020 |
Diagnostics for SARS-CoV-2 infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Nature materials 20 (5), 593-605, 2021 | 743 | 2021 |
Nanocarrier vaccines for SARS-CoV-2 J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Advanced Drug Delivery Reviews 171, 215-239, 2021 | 94 | 2021 |
A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Journal of Neuroimmune Pharmacology 16, 270-288, 2021 | 45 | 2021 |
CRISPR-Cas9 mediated exonic disruption for HIV-1 elimination J Herskovitz, M Hasan, M Patel, WR Blomberg, JD Cohen, J Machhi, ... EBioMedicine 73, 2021 | 35 | 2021 |
Europium-doped cerium oxide nanoparticles for microglial amyloid beta clearance and homeostasis J Machhi, P Yeapuri, M Markovic, M Patel, W Yan, Y Lu, JD Cohen, ... ACS chemical neuroscience 13 (8), 1232-1244, 2022 | 17 | 2022 |
The immunopathobiology of SARS-CoV-2 infection M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ... FEMS Microbiology Reviews 45 (6), fuab035, 2021 | 16 | 2021 |
Multipolymer microsphere delivery of SARS-CoV-2 antigens F Shahjin, M Patel, J Machhi, JD Cohen, MU Nayan, P Yeapuri, C Zhang, ... Acta Biomaterialia 158, 493-509, 2023 | 10 | 2023 |
Pharmacotherapeutics of SARS-CoV-2 Infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Journal of Neuroimmune Pharmacology, 1-26, 2021 | 10 | 2021 |
Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice P Yeapuri, J Machhi, Y Lu, MM Abdelmoaty, R Kadry, M Patel, S Bhattarai, ... Molecular neurodegeneration 18 (1), 97, 2023 | 6 | 2023 |
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy J Herskovitz, M Hasan, M Patel, BD Kevadiya, HE Gendelman HIV Reservoirs: Methods and Protocols, 429-445, 2022 | 4 | 2022 |
CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities HE Gendelman, M Patel, S Panja, LA Zaman, P Yeapuri, S Bhattarai, ... | | 2024 |
Lipid nanoparticle formulations and methods of use thereof HE Gendelman, J Herskovitz, M Hasan, B Kevadiya, M Patel US Patent App. 18/550,828, 2024 | | 2024 |
Development of a porous layer-by-layer microsphere with branched aliphatic hydrocarbon porogens F Shahjin, M Patel, M Hasan, JD Cohen, F Islam, M Ashaduzzaman, ... Nanomedicine: Nanotechnology, Biology and Medicine 48, 102644, 2023 | | 2023 |
LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF MP E. GENDELMAN, Howard, Jonathan HERSKOVITZ, Mahmudul HASAN, Bhavesh KEVADIYA US Patent 2022/198,229, 2022 | | 2022 |
Microparticle compositions and methods use thereof MP Howard E. Gendelman, Bhavesh Kevadiya, Farah Shahjin US Patent WO2,022,192,361, 2022 | | 2022 |
Exonic Disruption Facilitates Antiviral CRISPR-Cas9 Activity for Multistrain HIV-1 Elimination J Herskovitz, M Hasan, M Patel, WR Blomberg, JD Cohen, J Machhi, ... bioRxiv, 2021.01. 14.426544, 2021 | | 2021 |